Skip to main content
SpringerLink
Log in

Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Stress ulcer prophylaxis (SUP) is recommended in some situations to prevent upper gastrointestinal bleeding and is a component of standard care for patients admitted to the intensive care unit (ICU). Proton pump inhibitors (PPIs), already among the most widely prescribed drug classes, are being increasingly used. Objective To describe PPI prescribing patterns and their changes after the dissemination of guidelines. Setting Paediatric ICU (PICU), Robert-Debré Teaching Hospital, Paris, France, which admits about 800 patients annually, from full-term neonates to 18-year-olds. Method Prospective observational study with two 6-week observation periods (July–August and September–October, 2013), before and after dissemination in the PICU of PPI prescribing guidelines. Main outcome measure Changes in PPI prescribing patterns (prevalence, dosage, and indication) after the guidelines. Results The number of patients admitted to the PICU was 77 (mean age 4.6 years [range 1 day–18 years]) before and 70 (mean age 3.8 years [range 1 day–17 years]) after the guidelines. During both periods, SUP was the most common reason for PPI prescribing. The proportion of patients prescribed PPIs dropped significantly, from 51% before the guidelines to 30% after the guidelines (p < 0.001). Mean daily dosage also decreased significantly, from 1.5 mg/kg/(range 0.5–4.4) to 1.1 mg/kg (range 0.7–1.8) (p < 0.002). None of the patients experienced upper gastrointestinal bleeding during either period. Conclusion Off-label PPI prescribing for SUP was common in our PICU. The introduction of guidelines was associated with a significant decrease in PPI use and dosage. This study confirms that guidelines can change PPI prescribings patterns in paediatric practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ward RM, Kearns GL. Proton pump inhibitors in pediatrics. Paediatr Drugs. 2013;15:119–31.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Smith CH, Israel DM, Schreiber R, Goldman RD. Proton pump inhibitors for irritable infants. Can Fam Physician. 2013;59:153–6.

    PubMed  PubMed Central  Google Scholar 

  3. Tjon JA, Pe M, Soscia J, Mahant S. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease. Pharmacotherapy. 2013;33:956–71.

    Article  CAS  PubMed  Google Scholar 

  4. Tafuri G, Trotta F, Leufkens HGM, Martini N, Sagliocca L, Traversa G. Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease. Eur J Clin Pharmacol. 2009;65:209–16.

    Article  PubMed  Google Scholar 

  5. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999;15(56):347–79.

    Google Scholar 

  6. Krag M, Perner A, Wetterslev J, Møller MH. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review. Acta Anaesthesiol Scand. 2013;57:835–47.

    Article  CAS  PubMed  Google Scholar 

  7. Pimentel M, Roberts DE, Bernstein CN, Hoppensack M, Duerksen DR. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol. 2000;95:2801–6.

    Article  CAS  PubMed  Google Scholar 

  8. Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5:368–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med. 2013;41:693–705.

    Article  CAS  PubMed  Google Scholar 

  10. Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ. 2011;183:310–9.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170:784–90.

    Article  PubMed  Google Scholar 

  12. MacLaren R, Reynolds PM, Allen RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med. 2014;174:564–74.

    Article  PubMed  Google Scholar 

  13. Marik PE, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med. 2010;38:2222–8.

    Article  PubMed  Google Scholar 

  14. Heidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Ther Adv Gastroenterol. 2012;5:219–32.

    Article  Google Scholar 

  15. Thomas L, Culley EJ, Gladowski P, Goff V, Fong J, Marche SM. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization. J Manag Care Pharm. 2010;16:122–9.

    PubMed  Google Scholar 

  16. Lightdale JR, Gremse DA. Section on gastroenterology, hepatology and nutrition. Gastroesophageal reflux: management guidance for the pediatrician. Pediatrics. 2013;131:1684–95.

    Article  Google Scholar 

  17. French National Agency for the Safety of Medicines and Health Products. Good practice guidelines for the use of gastric anti-secretory agents in children issued in June 2008. http://www.omedit-hautenormandie.fr/Files/110_recommandations_antisecretoire_enfants.pdf. Accessed 08 Dec 2016.

  18. Winter H, Gunasekaran T, Tolia V, Gottrand F, Barker PN, Illueca M. Esomeprazole for the treatment of GERD in infants ages 1–11 months. J Pediatr Gastroenterol Nutr. 2012;55:14–20.

    Article  CAS  PubMed  Google Scholar 

  19. Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49:498–547.

    Article  PubMed  Google Scholar 

  20. Farrell CP, Mercogliano G, Kuntz CL. Overuse of stress ulcer prophylaxis in the critical care setting and beyond. J Crit Care. 2010;25:214–20.

    Article  PubMed  Google Scholar 

  21. Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med. 1988;16:1110–6.

    Article  CAS  PubMed  Google Scholar 

  22. Slater A, Shann F, Pearson G. Paediatric Index of Mortality (PIM) Study Group. PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med. 2003;29:278–85.

    Article  PubMed  Google Scholar 

  23. Leteurtre S, Duhamel A, Grandbastien B, Lacroix J, Leclerc F. Paediatric logistic organ dysfunction (PELOD) score. Lancet. 2006;367:897 (author reply 900–2).

    Article  PubMed  Google Scholar 

  24. Carnovale C, Conti V, Perrone V, Antoniazzi S, Pozzi M, Merlino L, et al. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches. Eur J Pediatr. 2013;172:1679–85.

    Article  PubMed  Google Scholar 

  25. Lenz K, Buder R, Firlinger F, Lohr G, Voglmayr M. Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress. Wien Klin Wochenschr. 2015;127:51–6.

    Article  CAS  PubMed  Google Scholar 

  26. Haroon M, Yasin F, Gardezi S, Adeeb F. Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study. JRSM Short Rep. 2013;4:1–6.

    Article  Google Scholar 

  27. Barletta JF, Kanji S, MacLaren R, Lat I, Erstad BL. American-Canadian consortium for Intensive care Drug utilization (ACID) Investigators. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. J Crit Care. 2014;29:955–60.

    Article  CAS  PubMed  Google Scholar 

  28. Gautam A, Ganu SS, Tegg OJ, Andresen DN, Wilkins BH, Schell DN. Ventilator-associated pneumonia in a tertiary paediatric intensive care unit: a 1-year prospective observational study. Crit Care Resusc. 2012;14:283–9.

    PubMed  Google Scholar 

  29. Atkins R, Smith L. Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting. Consult Pharm. 2013;28:786–92.

    Article  PubMed  Google Scholar 

  30. Leri F, Ayzenberg M, Voyce SJ, Klein A, Hartz L, Smego RA Jr. Four-year trends of inappropriate proton pump inhibitor use after hospital discharge. South Med J. 2013;106:270–3.

    Article  PubMed  Google Scholar 

  31. Machado-Alba JE, Castrillón-Spitia JD, Londoño-Builes MJ, Fernández-Cardona A, Campo-Betancourth CF, Ochoa-Orozco SA, et al. An economic analysis of inadequate prescription of antiulcer medications for in-hospital patients at a third level institution in Colombia. Rev Esp Enferm Dig. 2014;106:77–85.

    Article  PubMed  Google Scholar 

  32. MacLaren R, Campbell J. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients. Crit Care Med. 2014;42:809–15.

    Article  PubMed  Google Scholar 

  33. Barletta JF, Sclar DA. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences. Pharmacoeconomics. 2014;32:5–13.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

  1. Département de Pharmacie, Hôpital Robert-Debré, AP-HP, 48 boulevard Sérurier, 75395, Paris Cedex 19, France

    P. Joret-Descout, O. Bourdon & S. Prot-Labarthe

  2. Réanimation et surveillance continue pédiatrique, Hôpital Robert-Debré, AP-HP, Paris, France

    S. Dauger

  3. Université Paris 7- Paris Diderot, Paris, France

    S. Dauger

  4. INSERM U1141, Hôpital Robert-Debré, AP-HP, Paris, France

    S. Dauger

  5. Gastroentérologie pédiatrique, Hôpital Robert-Debré, AP-HP, Paris, France

    M. Bellaiche

  6. Pharmacie Clinique, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

    O. Bourdon

  7. Laboratoire Education et Pratiques de Santé, EA 3412, Université Paris 13, Sorbonne Paris Cité, Bobigny, France

    O. Bourdon & S. Prot-Labarthe

  8. INSERM, U1123, ECEVE, Paris, France

    S. Prot-Labarthe

Authors
  1. P. Joret-Descout
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Dauger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Bellaiche
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Bourdon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Prot-Labarthe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Prot-Labarthe.

Ethics declarations

Conflicts of Interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joret-Descout, P., Dauger, S., Bellaiche, M. et al. Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit. Int J Clin Pharm 39, 181–186 (2017). https://doi.org/10.1007/s11096-016-0420-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-016-0420-4

Keywords

Search

Navigation